BIOLINERX LTD-SPONS ADR (BLRX) Stock Price & Overview
NASDAQ:BLRX • US09071M2052
Current stock price
The current stock price of BLRX is 2.35 USD. Today BLRX is down by -1.26%. In the past month the price decreased by -12.18%. In the past year, price decreased by -17.36%.
BLRX Key Statistics
- Market Cap
- 10.226M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.32
- Dividend Yield
- N/A
BLRX Stock Performance
BLRX Stock Chart
BLRX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to BLRX. When comparing the yearly performance of all stocks, BLRX is a bad performer in the overall market: 85.27% of all stocks are doing better.
BLRX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BLRX. BLRX may be in some trouble as it scores bad on both profitability and health.
BLRX Earnings
BLRX Forecast & Estimates
BLRX Groups
Sector & Classification
BLRX Financial Highlights
Over the last trailing twelve months BLRX reported a non-GAAP Earnings per Share(EPS) of -1.32. The EPS increased by 87.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.48% | ||
| ROE | -15.24% | ||
| Debt/Equity | 0.34 |
BLRX Ownership
BLRX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.06 | 368.645B | ||
| AMGN | AMGEN INC | 15.23 | 187.715B | ||
| GILD | GILEAD SCIENCES INC | 15.71 | 173.485B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.66 | 112.351B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.99 | 79.706B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 47.96 | 44.214B | ||
| INSM | INSMED INC | N/A | 31.674B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 30.229B | ||
| NTRA | NATERA INC | N/A | 29.365B | ||
| BIIB | BIOGEN INC | 11.01 | 26.496B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.8 | 25.315B | ||
| MRNA | MODERNA INC | N/A | 21.519B | ||
| INCY | INCYTE CORP | 12.39 | 19.324B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BLRX
Company Profile
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Company Info
IPO: 2007-01-30
BIOLINERX LTD-SPONS ADR
Modi'in Technology Park, 2 HaMa'ayan Street
Modiin 7177871 IL
CEO: Philip A. Serlin
Employees: 28
Phone: 97286429100
BIOLINERX LTD-SPONS ADR / BLRX FAQ
Can you describe the business of BIOLINERX LTD-SPONS ADR?
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Can you provide the latest stock price for BIOLINERX LTD-SPONS ADR?
The current stock price of BLRX is 2.35 USD. The price decreased by -1.26% in the last trading session.
Does BIOLINERX LTD-SPONS ADR pay dividends?
BLRX does not pay a dividend.
What is the ChartMill rating of BIOLINERX LTD-SPONS ADR stock?
BLRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the valuation of BIOLINERX LTD-SPONS ADR (BLRX) based on its PE ratio?
BIOLINERX LTD-SPONS ADR (BLRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.32).
What is BIOLINERX LTD-SPONS ADR worth?
BIOLINERX LTD-SPONS ADR (BLRX) has a market capitalization of 10.23M USD. This makes BLRX a Nano Cap stock.